# General information about company
Scrip code | 972702
NSE Symbol |
MSEI Symbol |
ISIN* |
Name of company | NORTH EASTERN ELECTRIC POWER CORPORATION LIMITED
Type of company |
Class of security | Debt securities and/or non-cumulative redeemable preference shares
Date of start of financial year | 01-04-2023
Date of end of financial year | 31-03-2024
Date of board meeting when results were approved | 14-05-2024
Date on which prior intimation of the meeting for considering financial results was informed to the exchange | --
Description of presentation currency | INR
Level of rounding used in financial results | Lakhs
Reporting Quarter | Yearly
Nature of report standalone or consolidated | Standalone
Whether results are audited or unaudited | Audited
Segment Reporting | Single segment
Description of single segment | Generation of Electricity
Start date and time of board meeting | 14-05-2024 16:30
End date and time of board meeting | 14-05-2024 18:35
Whether cash flow statement is applicable on company | Yes
Type of cash flow statement | Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion

# Financial Results – Ind-AS
Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy)
A | Date of start of reporting period | 01-10-2023 | 01-04-2023
B | Date of end of reporting period | 31-03-2024 | 31-03-2024
C | Whether results are audited or unaudited | Audited | Audited
D | Nature of report standalone or consolidated | Standalone | Standalone
Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 | Income
| Revenue from operations | 188968.05 | 423956.74
| Other income | 871.64 | 2466.09
| Total income | 189839.69 | 426422.83
2 | Expenses
(a) | Cost of materials consumed | 61560.74 | 125642.24
(b) | Purchases of stock-in-trade | 0 | 0
(c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0 | 0
(d) | Employee benefit expense | 20443.01 | 43285.78
(e) | Finance costs | 26282.05 | 52838.05
(f) | Depreciation, depletion and amortisation expense | 41833.56 | 85480.64
(f) | Other Expenses
1 | Other Expenses | 31003.15 | 56957.35
10 |  |  |
| Total other expenses | 31003.15 | 56957.35
| Total expenses | 181122.51 | 364204.06

# Financial Results – Ind-AS
Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy)
A | Date of start of reporting period | 01-10-2023 | 01-04-2023
B | Date of end of reporting period | 31-03-2024 | 31-03-2024
C | Whether results are audited or unaudited | Audited | Audited
D | Nature of report standalone or consolidated | Standalone | Standalone
Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3 | Total profit before exceptional items and tax | 8717.18 | 62218.77
4 | Exceptional items | 0 | 0
5 | Total profit before tax | 8717.18 | 62218.77
7 | Tax expense
8 | Current tax | 1233.54 | 10252.95
9 | Deferred tax | -23741.67 | -5347.73
10 | Total tax expenses | -22508.13 | 4905.22
11 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | -8977.72 | -2501.34
14 | Net Profit Loss for the period from continuing operations | 22247.59 | 54812.21
15 | Profit (loss) from discontinued operations before tax | 0 | 0
16 | Tax expense of discontinued operations | 0 | 0
17 | Net profit (loss) from discontinued operation after tax | 0 | 0
19 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0 | 0
21 | Total profit (loss) for period | 22247.59 | 54812.21
22 | Other comprehensive income net of taxes | -762.84 | -1606.63

# Financial Results – Ind-AS
Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy)
A | Date of start of reporting period | 01-10-2023 | 01-04-2023
B | Date of end of reporting period | 31-03-2024 | 31-03-2024
C | Whether results are audited or unaudited | Audited | Audited
D | Nature of report standalone or consolidated | Standalone | Standalone
Part I | Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23 | Total Comprehensive Income for the period | 21484.75 | 53205.58
24 | Total profit or loss, attributable to
| Profit or loss, attributable to owners of parent |  |
| Total profit or loss, attributable to non-controlling interests |  |
25 | Total Comprehensive income for the period attributable to
| Comprehensive income for the period attributable to owners of parent | 0 | 0
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0 | 0
26 | Details of equity share capital
| Paid-up equity share capital | 360981.04 | 360981.04
| Face value of equity share capital | 10 | 10
27 | Details of debt securities
28 | Reserves excluding revaluation reserve |  | 0
29 | Earnings per share
i | Earnings per equity share for continuing operations
| Basic earnings (loss) per share from continuing operations | 0.62 | 1.52
| Diluted earnings (loss) per share from continuing operations | 0.87 | 1.59
ii | Earnings per equity share for discontinued operations
| Basic earnings (loss) per share from discontinued operations | 0 | 0
| Diluted earnings (loss) per share from discontinued operations | 0 | 0
ii | Earnings per equity share
| Basic earnings (loss) per share from continuing and discontinued operations | 0.62 | 1.52
| Diluted earnings (loss) per share from continuing and discontinued operations | 0.87 | 1.59
30 | Debt equity ratio | 1.09 | 1.09
31 | Debt service coverage ratio | 1.14 | 1.14
32 | Interest service coverage ratio | 3.74 | 3.74
33 | Disclosure of notes on financial results |

# Statement of Asset and Liabilities
Particulars | Current year ended (dd-mm-yyyy)
Date of start of reporting period | 01-04-2023
Date of end of reporting period | 31-03-2024
Whether results are audited or unaudited | Audited
Nature of report standalone or consolidated | Standalone
| Assets
1 | Non-current assets
| Property, plant and equipment | 1293125.26
| Capital work-in-progress | 66482.49
| Investment property |
| Goodwill | 0
| Other intangible assets | 8033.31
| Intangible assets under development | 124.32
| Biological assets other than bearer plants |
| Investments accounted for using equity method |
| Non-current financial assets
| Non-current investments | 0
| Trade receivables, non-current |
| Loans, non-current | 40.02
| Other non-current financial assets | 43529.96
| Total non-current financial assets | 43569.98
| Deferred tax assets (net) |
| Other non-current assets |
| Total non-current assets | 1411335.36
2 | Current assets
| Inventories | 12457.35
| Current financial asset
| Current investments | 0
| Trade receivables, current | 83664.74
| Cash and cash equivalents | 240.1
| Bank balance other than cash and cash equivalents | 276.46
| Loans, current | 0
| Other current financial assets | 32756.4
| Total current financial assets | 116937.7
| Current tax assets (net) | 2165.84
| Other current assets | 2509.47
| Total current assets | 134070.36

# Statement of Asset and Liabilities
Particulars | Current year ended (dd-mm-yyyy)
Date of start of reporting period | 01-04-2023
Date of end of reporting period | 31-03-2024
Whether results are audited or unaudited | Audited
Nature of report standalone or consolidated | Standalone
3 | Non-current assets classified as held for sale |
4 | Regulatory deferral account debit balances and related deferred tax Assets | 114729.55
| Total assets | 1660135.27
| Equity and liabilities
| Equity
| Equity attributable to owners of parent
| Equity share capital | 360981.04
| Other equity | 325808.33
| Total equity attributable to owners of parent | 686789.37
| Non controlling interest |
| Total equity | 686789.37
| Liabilities
| Non-current liabilities
| Non-current financial liabilities
| Borrowings, non-current | 590470.25
| Trade payables, non-current | 0
| Other non-current financial liabilities | 1015.07
| Total non-current financial liabilities | 591485.32
| Provisions, non-current | 303.28
| Deferred tax liabilities (net) | 93440.22
| Deferred government grants, Non-current |
| Other non-current liabilities | 19627.01
| Total non-current liabilities | 704855.83
| Current liabilities
| Current financial liabilities
| Borrowings, current | 151170.54
| Trade payables, current | 17775.74
| Other current financial liabilities | 43691.48
| Total current financial liabilities | 212637.76
| Other current liabilities | 6228.16
| Provisions, current | 19930.75
| Current tax liabilities (Net) | 0
| Deferred government grants, Current | 11564.74
| Total current liabilities | 250361.41
3 | Liabilities directly associated with assets in disposal group classified as held for sale |
4 | Regulatory deferral account credit balances and related deferred tax liability | 18128.66
| Total liabilities | 973345.9
| Total equity and liabilites | 1660135.27
| Disclosure of notes on assets and liabilities |

# Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period | 01-10-2023 | 01-04-2023
Date of end of reporting period | 31-03-2024 | 31-03-2024
Whether accounts are audited or unaudited | Audited | Audited
Nature of report standalone or consolidated | Standalone | Standalone
1 | Segment Revenue (Income)
| (net sale/income from each segment should be disclosed)
| Total Segment Revenue |  |
| Less: Inter segment revenue |  |
| Revenue from operations |  |
2 | Segment Result
| Profit (+) / Loss (-) before tax and interest from each segment
| Total Profit before tax |  |
| i. Finance cost |  |
| ii. Other Unallocable Expenditure net off Unallocable income |  |
| Profit before tax |  |
3 | (Segment Asset - Segment Liabilities)
| Segment Asset
| Total Segment Asset |  |
| Un-allocable Assets |  |
| Net Segment Asset |  |
4 | Segment Liabilities
| Segment Liabilities
| Total Segment Liabilities |  |
| Un-allocable Liabilities |  |
| Net Segment Liabilities |  |
| Disclosure of notes on segments |

# Cash flow statement, indirect
Particulars | Year ended (dd-mm-yyyy)
A | Date of start of reporting period | 01-04-2023
B | Date of end of reporting period | 31-03-2024
C | Whether results are audited or unaudited | Audited
D | Nature of report standalone or consolidated | Standalone
Part I | Blue color marked fields are non-mandatory.
| Statement of cash flows |
| Cash flows from used in operating activities |
| Profit before tax | 62218.77
| Adjustments for reconcile profit (loss) |
| Adjustments for finance costs | 52744.49
| Adjustments for decrease (increase) in inventories | 58.7
| Adjustments for decrease (increase) in trade receivables, current | 10909.37
| Adjustments for decrease (increase) in trade receivables, non-current | 0
| Adjustments for decrease (increase) in other current assets | -10695.48
| Adjustments for decrease (increase) in other non-current assets | 0
| Adjustments for other financial assets, non-current | 0
| Adjustments for other financial assets, current | 0
| Adjustments for other bank balances | 0
| Adjustments for increase (decrease) in trade payables, current | -40522.39
| Adjustments for increase (decrease) in trade payables, non-current | 0
| Adjustments for increase (decrease) in other current liabilities | 0
| Adjustments for increase (decrease) in other non-current liabilities | 0
| Adjustments for depreciation and amortisation expense | 85480.64
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0
| Adjustments for provisions, current | 7109.36
| Adjustments for provisions, non-current | 0
| Adjustments for other financial liabilities, current | 0
| Adjustments for other financial liabilities, non-current | 0
| Adjustments for unrealised foreign exchange losses gains | 0
| Adjustments for dividend income | 0
| Adjustments for interest income | 0
| Adjustments for share-based payments | 0
| Adjustments for fair value losses (gains) | 0
| Adjustments for undistributed profits of associates | 0
| Other adjustments for which cash effects are investing or financing cash flow | 0
| Other adjustments to reconcile profit (loss) | 0
| Other adjustments for non-cash items | -2799.71
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0
| Total adjustments for reconcile profit (loss) | 102284.98
| Net cash flows from (used in) operations | 164503.75
| Dividends received | 0
| Interest paid | 0
| Interest received | 0
| Income taxes paid (refund) | 10400
| Other inflows (outflows) of cash | 0
| Net cash flows from (used in) operating activities | 154103.75
| Cash flows from used in investing activities |
| Cash flows from losing control of subsidiaries or other businesses | 0
| Cash flows used in obtaining control of subsidiaries or other businesses | 0
| Other cash receipts from sales of equity or debt instruments of other entities | 0
| Other cash payments to acquire equity or debt instruments of other entities | 0
| Other cash receipts from sales of interests in joint ventures | 0
| Other cash payments to acquire interests in joint ventures | 0
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0
| Proceeds from sales of property, plant and equipment | -71.14
| Purchase of property, plant and equipment | 108766.59
| Proceeds from sales of investment property | 0
| Purchase of investment property | 0
| Proceeds from sales of intangible assets | 0
| Purchase of intangible assets | 0
| Proceeds from sales of intangible assets under development | 0
| Purchase of intangible assets under development | 0
| Proceeds from sales of goodwill | 0
| Purchase of goodwill | 0
| Proceeds from biological assets other than bearer plants | 0
| Purchase of biological assets other than bearer plants | 0
| Proceeds from government grants | 0
| Proceeds from sales of other long-term assets | 0
| Purchase of other long-term assets | 0
| Cash advances and loans made to other parties | 0
| Cash receipts from repayment of advances and loans made to other parties | 0
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0
| Dividends received | 0
| Interest received | -358.77
| Income taxes paid (refund) | 0
| Other inflows (outflows) of cash | 1579.41
| Net cash flows from (used in) investing activities | -107617.09
| Cash flows from used in financing activities |
| Proceeds from changes in ownership interests in subsidiaries | 0
| Payments from changes in ownership interests in subsidiaries | 0
| Proceeds from issuing shares | 0
| Proceeds from issuing other equity instruments | 0
| Payments to acquire or redeem entity's shares | 0
| Payments of other equity instruments | 0
| Proceeds from exercise of stock options | 0
| Proceeds from issuing debentures notes bonds etc | 0
| Proceeds from borrowings | 155056.76
| Repayments of borrowings | -120462.09
| Payments of finance lease liabilities | 0
| Payments of lease liabilities | -1056.94
| Dividends paid | -25000
| Interest paid | -56245.63
| Income taxes paid (refund) | 0
| Other inflows (outflows) of cash | -405529.32
| Net cash flows from (used in) financing activities | -47707.9
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | -1221.24
| Effect of exchange rate changes on cash and cash equivalents |
| Effect of exchange rate changes on cash and cash equivalents | 0
| Net increase (decrease) in cash and cash equivalents | -1221.24
| Cash and cash equivalents cash flow statement at beginning of period | 1461.34
| Cash and cash equivalents cash flow statement at end of period | 240.1